Pauwels E, Cleeren F, Bormans G, Deroose CM. Somatostatin receptor PET ligands - the next generation for clinical practice. Am J Nucl Med Mol Imaging. 2018;8:311–31.

CAS  PubMed  PubMed Central  Google Scholar 

Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, et al. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989;1:242–4.

Article  CAS  PubMed  Google Scholar 

Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schafer M, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007;34:1617–26.

Article  CAS  PubMed  Google Scholar 

Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape UF, et al. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39:72–82.

Article  PubMed  Google Scholar 

Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, et al. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med. 2001;42:1053–6.

CAS  PubMed  Google Scholar 

Hanscheid H, Sweeney RA, Flentje M, Buck AK, Lohr M, Samnick S, et al. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma. Eur J Nucl Med Mol Imaging. 2012;39:1284–8.

Article  PubMed  Google Scholar 

Parghane RV, Talole S, Basu S. Prevalence of hitherto unknown brain meningioma detected on (68)Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of (177)Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors. World J Nucl Med. 2019;18:160–70.

Article  PubMed  PubMed Central  Google Scholar 

Kuyumcu S, Ozkan ZG, Sanli Y, Yilmaz E, Mudun A, Adalet I, Unal S. Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation. Ann Nucl Med. 2013;27:538–45.

Article  CAS  PubMed  Google Scholar 

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, et al. Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging. 2017;44:2150–1.

Article  PubMed  Google Scholar 

Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging. 2010;54:61–7.

CAS  PubMed  Google Scholar 

Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N. Overview of radiolabeled somatostatin analogs for cancer imaging and therapy. Molecules. 2020;25:4012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu W, Zhou Y, Wang Y, Liu L, Lou J, Deng Y, et al. Clinical significance of somatostatin receptor (SSTR) 2 in meningioma. Front Oncol. 2020;10:1633.

Article  PubMed  PubMed Central  Google Scholar 

Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004–10.

Article  PubMed  Google Scholar 

Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500–16.

Article  PubMed  Google Scholar 

Wild D, Macke HR, Waser B, Reubi JC, Ginj M, Rasch H, et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging. 2005;32:724.

Article  PubMed  Google Scholar 

Albano D, Treglia G, Dondi F, Bertagna F. Prevalence of Brain Incidental lesions detected by (68)Ga-DOTA peptides PET/CT. Med (Kaunas). 2022;58.

Ozguven S, Filizoglu N, Kesim S, Oksuzoglu K, Sen F, Ones T, et al. Physiological biodistribution of (68)Ga-DOTA-TATE in normal subjects. Mol Imaging Radionucl Ther. 2021;30:39–46.

Article  PubMed  PubMed Central  Google Scholar 

Filippi L, Palumbo I, Bagni O, Schillaci O, Aristei C, Palumbo B. Somatostatin receptor targeted PET-imaging for diagnosis, radiotherapy planning and theranostics of meningiomas: a systematic review of the literature. Diagnostics (Basel). 2022;12:1666.

Article  CAS  PubMed  Google Scholar 

Purandare NC, Puranik A, Shah S, Agrawal A, Gupta T, Moiyadi A, et al. Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CT. Nucl Med Commun. 2020;41:356–62.

Article  CAS  PubMed  Google Scholar 

Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17:e383–91.

Article  PubMed  Google Scholar 

Golemi A, Ambrosini A, Cecchi P, Ruiu A, Chondrogiannis S, Farsad M, Rubello D. (68)Ga-DOTANOC PET/CT detection of multiple extracranial localizations in a patient with anaplastic meningioma. Rev Esp Med Nucl Imagen Mol. 2015;34:258–60.

CAS  PubMed  Google Scholar 

Klingenstein A, Haug AR, Miller C, Hintschich C. Ga-68-DOTA-TATE PET/CT for discrimination of tumors of the optic pathway. Orbit. 2015;34:16–22.

Article  PubMed  Google Scholar 

Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. The use of (68)Ga-DOTATATE PET/CT in the non-invasive diagnosis of optic nerve sheath meningioma: a case report. Front Oncol. 2018;8:454.

Article  PubMed  PubMed Central  Google Scholar 

Florio T, Montella L, Corsaro A, De Chiara A, Apice G, Fazioli F, et al. In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors. Anticancer Res. 2003;23:2465–71.

CAS  PubMed  Google Scholar 

Ferrari S, Dondi M, Fanti S, Zoboli S, Giacomini S, Mercuri M, Bacci G. Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma. Cancer Biother Radiopharm. 2003;18:847–51.

CAS  PubMed  Google Scholar 

Friedberg JW, Van den Abbeele AD, Kehoe K, Singer S, Fletcher CD, Demetri GD. Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma. Cancer. 1999;86:1621–7.

Article  CAS  PubMed  Google Scholar 

Kumar A, Jindal T, Dutta R, Kumar R. Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan. Ann Nucl Med. 2009;23:745–51.

Article  PubMed  Google Scholar